GILD

Gilead Sciences Inc.

Price

$146.33

return (12m)

33.60%

p/e

-55.74

p/bv

15.38

DIVIDEND YIELD

2.22%

GILD price

Gilead Sciences

If you had invested

exposure

years ago

ago, you would now have *

ago, you would now have:

*This calculation reflects price variation only.

Return on Investment GILD

1 month

3 months

1 year

2 years

5 years

10 years

return

1 month

13.42%

3 months

16.11%

1 year

33.60%

2 years

97.29%

5 years

144.20%

10 years

169.30%

Asset Comparator

If you had invested

years ago

ago, you would now have *

ago, you would now have:

*This calculation reflects price variation only.

Fundamentals GILD

Valuation

P/E

-55.74

Sector -4.18

Industry -4.18

P/BV

15.38

Sector 2.11

Industry 2.11

P/Revenue (PSR)

5.93

Sector 2.02

Industry 2.02

EV/EBITDA

Sector -546.31

Industry -546.31

EV/EBIT

Sector -37.46

Industry -37.46

P/EBITDA

Sector -51.62

Industry -51.62

P/EBIT

Sector -39.91

Industry -39.91

P/Total Assets

3.66

Sector 1.25

Industry 1.25

P/Net Current Assets

-7.95

Sector -5.50

Industry -5.50

P/Working Capital

61.75

Sector -1.24

Industry -1.24

EPS

-2.61

Sector -1.92

Industry -1.92

BVPS

9.45

Sector 1.91

Industry 1.91

Efficiency

Gross Margin

79.59%

Sector 39.00%

Industry 39.00%

EBITDA Margin

0.00%

Sector -13,872.56%

Industry -13,872.56%

EBIT Margin

0.00%

Sector -4,253,834.43%

Industry -4,253,834.43%

Operating Margin

-8.20%

Sector -36.46%

Industry -36.46%

Net Profit Margins

-10.64%

Sector -37.25%

Industry -37.25%

Asset Turnover

0.16

Sector 0.03

Industry 0.03

Profitability

ROE

-27.59%

Sector -60.65%

Industry -60.65%

ROA

-6.56%

Sector -63.20%

Industry -63.20%

ROIC

0.00%

Sector -498.30%

Industry -498.30%

Dividends

Dividend yield

2.22%

Sector -

Industry -

Payout

Sector -

Industry -

Debt

Current Ratio

1.27

Sector 2.89

Industry 2.89

Net Debt / EBITDA

Sector -39,048,222.71

Industry -39,048,222.71

Net Debt / EBIT

Sector -10.24

Industry -10.24

Net Debt / Equity

2.03

Sector -0.60

Industry -0.60

Gross Debt / Equity

2.03

Sector -0.83

Industry -0.83

Equity/Assets

0.24

Sector 0.43

Industry 0.43

Liabilities/Assets

0.74

Sector 0.39

Industry 0.39

Growth

5Y Revenue CAGR

2.21%

Sector -

Industry -

5Y Earnings CAGR

0.00%

Sector -

Industry -

Fundamentals GILD

DRAG THE FRAME TO SEE MORE DATA

Assets	Price (US$)	Return 12m	DY	P/E	P/BV	ROE	Net Profit Margins
GILD Gilead Sciences Inc.	$146.33	33.60%	2.22%	-55.74	15.38	-27.59%	-10.64%
JNJ Johnson & Johnson	$266.00	54.66%	1.98%	30.34	7.51	24.76%	21.48%
PFE Pfizer Inc.	$28.34	24.62%	6.28%	35.72	1.83	5.11%	6.86%
ABBV AbbVie Inc.	$256.18	25.64%	2.66%	72.02	-76.66	-106.44%	9.81%
NVO Novo Nordisk A/S	$45.54	-15.32%	4.06%	11.16	5.92	53.11%	35.32%
MRK Merck & Co. Inc.	$147.89	82.67%	2.29%	114.53	8.64	7.55%	4.76%
AZN AstraZeneca PLC	$162.44	4.13%	1.99%	23.89	4.95	20.74%	17.02%
BMY Bristol-Myers Squibb Company	$66.56	47.76%	3.79%	14.60	6.06	41.55%	18.85%
ZTS Zoetis Inc.	$76.99	-49.66%	2.68%	12.14	10.20	84.02%	27.77%
AMGN Amgen Inc.	$431.28	55.28%	2.28%	26.55	19.86	74.80%	22.95%
REGN Regeneron Pharmaceuticals Inc.	$795.78	37.79%	0.58%	18.86	2.57	13.65%	27.86%
HALO Halozyme Therapeutics Inc.	$105.85	44.70%	0.00%	29.70	85.59	288.14%	24.86%
MCK McKesson Corporation	$885.76	29.66%	0.37%	20.12	-27.60	-137.16%	1.29%
VRTX Vertex Pharmaceuticals Incorporated	$540.04	38.11%	0.00%	31.27	6.80	21.76%	35.00%
CAH Cardinal Health Inc.	$235.36	60.21%	0.87%	35.62	-20.64	-57.93%	0.62%
HRMY Harmony Biosciences Holdings Inc.	$39.65	7.48%	0.00%	12.57	2.28	18.14%	18.89%
ARGX argenx SE	$1,019.82	43.19%	0.00%	3.11	3.48	112.18%	44.41%
BIIB Biogen Inc.	$218.35	65.14%	0.00%	38.52	1.71	4.43%	8.32%

Stock vs Indice Comparison Tool

If you had invested

years ago

ago, you would now have *

ago, you would now have:

*This calculation reflects price variation only.

GILD Historical Dividends

current DY: 2.22%

5-year average DY: 3.70%

DRAG THE FRAME TO SEE MORE DATA

type	Ex - Dividend Date	payment date	value
Dividends	09/14/2026	09/29/2026	0.82000000
Dividends	06/12/2026	06/29/2026	0.82000000
Dividends	03/12/2026	03/30/2026	0.82000000
Dividends	12/12/2025	12/30/2025	0.79000000
Dividends	09/12/2025	09/29/2025	0.79000000
Dividends	06/12/2025	06/27/2025	0.79000000
Dividends	03/13/2025	03/28/2025	0.79000000
Dividends	12/12/2024	12/30/2024	0.77000000
Dividends	09/12/2024	09/27/2024	0.77000000
Dividends	06/13/2024	06/27/2024	0.77000000
Dividends	03/13/2024	03/28/2024	0.77000000
Dividends	12/13/2023	12/28/2023	0.75000000
Dividends	09/13/2023	09/28/2023	0.75000000
Dividends	06/13/2023	06/29/2023	0.75000000
Dividends	03/13/2023	03/30/2023	0.75000000
Dividends	12/13/2022	12/29/2022	0.73000000
Dividends	09/13/2022	09/29/2022	0.73000000
Dividends	06/13/2022	06/29/2022	0.73000000
Dividends	03/11/2022	03/30/2022	0.73000000
Dividends	12/13/2021	12/30/2021	0.71000000
Dividends	09/13/2021	09/29/2021	0.71000000
Dividends	06/11/2021	06/29/2021	0.71000000
Dividends	03/11/2021	03/30/2021	0.71000000
Dividends	12/11/2020	12/30/2020	0.68000000
Dividends	09/11/2020	09/29/2020	0.68000000
Dividends	06/10/2020	06/29/2020	0.68000000
Dividends	03/11/2020	03/30/2020	0.68000000
Dividends	12/11/2019	12/30/2019	0.63000000
Dividends	09/11/2019	09/27/2019	0.63000000
Dividends	06/12/2019	06/27/2019	0.63000000
Dividends	03/13/2019	03/28/2019	0.63000000
Dividends	12/12/2018	12/28/2018	0.57000000
Dividends	09/12/2018	09/27/2018	0.57000000
Dividends	06/13/2018	06/28/2018	0.57000000
Dividends	03/14/2018	03/29/2018	0.57000000
Dividends	12/13/2017	12/28/2017	0.52000000
Dividends	09/13/2017	09/28/2017	0.52000000
Dividends	06/14/2017	06/29/2017	0.52000000
Dividends	03/14/2017	03/30/2017	0.52000000
Dividends	12/13/2016	12/29/2016	0.47000000
Dividends	09/14/2016	09/29/2016	0.47000000
Dividends	06/14/2016	06/29/2016	0.47000000
Dividends	03/14/2016	03/30/2016	0.43000000
Dividends	12/14/2015	12/30/2015	0.43000000
Dividends	09/14/2015	09/29/2015	0.43000000
Dividends	06/12/2015	06/29/2015	0.43000000

ABOUT Gilead Sciences

Gilead Sciences Inc.

Average Investor10 user rating

4.0 (89 people)

United States

39 years

Founded: 1987

1992

Time since IPO - 34 years

13.600

Employees

Gilead Sciences Inc. (United States) is listed on the Nasdaq and has a market capitalization of $180.61 billion, with shareholders equity totaling $11.74 billion.

The company employs approximately 13.600 people and operates in the Health Care sector, within the Biotechnology industry.

Over the past 12 months, Gilead Sciences Inc. reported $30.46 billion in revenue, generating net income of $-3.24 billion.

Key financial metrics include a P/E ratio of -55.74, a price-to-book (P/B) ratio of 15.38, and a trailing twelve-month dividend yield of 2.22%.

The company trades under the ticker GILD.

Market cap

$180.61 billion

Net worth

$11.74 billion

$11,744,000,000.00

Assets

$49.36 billion

$49,362,000,000.00

Total Shares Outstanding

1.24 billion

1,243,000,000

Average Daily Trading Volume

$7.06 million

$7,062,596.00

Sector

Health Care

Industry

Biotechnology

GILD

revenue by Business Segment Gilead Sciences

Revenue by Region Gilead Sciences

GILD revenue and profits

Financial Results GILD

DRAG THE FRAME TO SEE MORE DATA

GILD cash flow

DRAG THE FRAME TO SEE MORE DATA

Discover more assets

BFRA - Biofrontera

$- -0,00% (12M)

P/E

0.00

0.00%

ROE

-893.55%

P/BV

0.00

MCK - McKesson

$885.76 29,66% (12M)

P/E

20.12

0.37%

ROE

-137.16%

P/BV

-27.60

CAH - Cardinal Health

$235.36 60,21% (12M)

P/E

35.62

0.87%

ROE

-57.93%

P/BV

-20.64

JNJ - Johnson & Johnson

$266.00 54,66% (12M)

P/E

30.34

1.98%

ROE

24.76%

P/BV

7.51

ABBV - AbbVie

$256.18 25,64% (12M)

P/E

72.02

2.66%

ROE

-106.44%

P/BV

-76.66

MRK - Merck & Co.

$147.89 82,67% (12M)

P/E

114.53

2.29%

ROE

7.55%

P/BV

8.64

AZN - AstraZeneca

$162.44 3,75% (12M)

P/E

23.89

1.99%

ROE

20.74%

P/BV

4.95

PFE - Pfizer

$28.34 24,62% (12M)

P/E

35.72

6.28%

ROE

5.11%

P/BV

1.83

BFRA - Biofrontera

$- -0,00% (12 M)

P/L

0.00

0.00%

ROE

-893.55%

P/VP

0.00

MCK - McKesson

$885.76 29,66% (12 M)

P/L

20.12

0.37%

ROE

-137.16%

P/VP

-27.60

CAH - Cardinal Health

$235.36 60,21% (12 M)

P/L

35.62

0.87%

ROE

-57.93%

P/VP

-20.64

JNJ - Johnson & Johnson

$266.00 54,66% (12 M)

P/L

30.34

1.98%

ROE

24.76%

P/VP

7.51

ABBV - AbbVie

$256.18 25,64% (12 M)

P/L

72.02

2.66%

ROE

-106.44%

P/VP

-76.66

MRK - Merck & Co.

$147.89 82,67% (12 M)

P/L

114.53

2.29%

ROE

7.55%

P/VP

8.64

AZN - AstraZeneca

$162.44 3,75% (12 M)

P/L

23.89

1.99%

ROE

20.74%

P/VP

4.95

PFE - Pfizer

$28.34 24,62% (12 M)

P/L

35.72

6.28%

ROE

5.11%

P/VP

1.83

Frequently Asked Questions

What is the price of Gilead Sciences (GILD) today?

A cotação de Gilead Sciences (GILD) hoje está em US$ 146.33, com uma variação de 33.6% em relação ao último ano. A cotação de Gilead Sciences (GILD) iniciou o ano negociando na casa dos US$ 122.74 e hoje está em US$ 146.33. Acompanhe o gráfico de cotação em tempo real, a cotação histórica de Gilead Sciences (GILD) e dados de ações do Ibovespa e mercados internacionais.

Quando Gilead Sciences (GILD) paga dividendos?

Gilead Sciences (GILD) distribuiu dividendos no último ano,in the months of March and June totalizando R$ 1.64. O Dividend Yield referente aos 12 últimos meses é de 2.22%.

Is Gilead Sciences (GILD) a good investment?

Atualmente, Gilead Sciences (GILD) está cotada a US$ 146.33, com um P/L de -55.74, representando um desvio de 4,555% em relação ao seu P/L médio histórico. No último ano, a ação apresentou uma variação de 33.6 em sua cotação e distribuiu US$ 1.64 em dividendos, resultando em um Dividend Yield de 2.22%. O retorno total do acionista foi de 33.60%.

Investors should keep in mind that past performance does not guarantee future results. This information is provided for educational purposes only and should not be considered investment advice.

How can I buy Gilead Sciences (GILD) stock?

Investir em ações de Gilead Sciences (GILD) pode ser feito de duas formas: comprando a stock uma empresa estrangeira e é atrelado ao dólar.

How much would 100 shares of Gilead Sciences (GILD) yield today?

A rentabilidade de Gilead Sciences (GILD) foi de 13.42% no último mês, 33.60% no último ano e 144.20% nos últimos 5 anos (já considerando valorização e dividendos).

Nos últimos 12 meses, a empresa pagou um total de US$ 3.22 em dividendos, um Dividend Yield de 2.22%.

Se você quisesse comprar 100 ações de Gilead Sciences (GILD) hoje, o investimento total seria de US$ 14,633.00, com base na cotação atual de US$ 146.33.

Based on historical performance, the investment would have grown to approximately:

Em 1 ano: US$ 19,549.69
Em 5 anos: US$ 35,733.79
Em 10 anos: US$ 39,406.67

Past performance does not guarantee future results. This content is for informational purposes only and should not be considered investment advice.

GILD

Gilead Sciences Inc.

Price

return (12m)

p/e

p/bv

DIVIDEND YIELD

Return on Investment GILD

Valuation

Efficiency

Profitability

Dividends

Debt

Growth

COMPARING GILD WITH OTHER STOCK

current DY: 2.22%

5-year average DY: 3.70%

type

Ex - Dividend Date

payment date

value

ABOUT Gilead Sciences

Gilead Sciences Inc.

United States

39 years

1992

13.600

PROFIT X PRICE GILD

Financial Results GILD

GILD cash flow

Asset, Revenue and Profit Growth - GILD

GILD balance sheet

BFRA - Biofrontera

MCK - McKesson

CAH - Cardinal Health

JNJ - Johnson & Johnson

ABBV - AbbVie

MRK - Merck & Co.

AZN - AstraZeneca

PFE - Pfizer

BFRA - Biofrontera

MCK - McKesson

CAH - Cardinal Health

JNJ - Johnson & Johnson

ABBV - AbbVie

MRK - Merck & Co.

AZN - AstraZeneca

PFE - Pfizer

Frequently Asked Questions